Health ❯ Healthcare ❯ Pharmaceuticals ❯ Drug Development

Clinical Trials

Nuvation Bio Reports Q1 Growth as Iptrozy Moves Earlier in ROS1 Lung Cancer Care

Durable results are pushing doctors to start the drug first.

Q1 Earnings: Exxon Tops Adjusted Forecasts as Middle East Turmoil Skews Oil Majors’ Results

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

Regeneron Tops Q1 Estimates as Dupixent and Libtayo Outpace Eylea

FDA Launches First Real-Time Clinical Trial Pilot With AstraZeneca and Amgen

FDA Approves First Gene Therapy for Inherited Hearing Loss

Trump Seals Regeneron Drug-Pricing Pact, Completing 17-Company Push

KRAS Pill Doubles Survival in Trial as Pancreatic Cancer Vaccine Advances

Merck and Other Drugmakers Weigh Bids for Inhibrx’s Keytruda-Linked Cancer Drug

Roche Files MS Drug Fenebrutinib With Regulators Despite Trial Deaths

Revolution Medicines’ Pancreatic Cancer Drug Lands ASCO Plenary After Phase 3 Survival Gain

Major Review Says New Alzheimer’s Antibodies Offer No Meaningful Benefit

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

Revolution Medicines Drug Nearly Doubles Survival in Phase 3 Pancreatic Cancer Trial

FDA Approves Filspari to Reduce Proteinuria in FSGS Patients Without Nephrotic Syndrome

Spyre Drug Meets Midstage Target in Ulcerative Colitis, Stock Rallies

Jeito Capital Closes $1.2 Billion Second Fund in Claimed European Biopharma Record

Insmed Halts Brensocatib in Hidradenitis Suppurativa After Phase 2b Trial Fails

Corcept Investors Face April 21 Deadline to Seek Lead Role in Securities Case Over Relacorilant

Cyclerion to Merge With Korsana in Reverse Takeover Backed by $380 Million